116 related articles for article (PubMed ID: 3064802)
21. Risk of virus transmission and sterilization practices of dermatologists.
Caumes E; Roujeau JC
J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):324. PubMed ID: 2768589
[No Abstract] [Full Text] [Related]
22. Transfusion transmitted viral infections--recent developments in blood donor screening.
Yap PL
Postgrad Med J; 1990 Nov; 66(781):906-9. PubMed ID: 2176286
[No Abstract] [Full Text] [Related]
23. Symposium on transfusion-associated infections and immune response.
Vyas GN
Transfus Med Rev; 1988 Dec; 2(4):193-5. PubMed ID: 2980087
[No Abstract] [Full Text] [Related]
24. Specific inactivation of viruses which can potentially contaminate blood products.
Horowitz B
Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631
[TBL] [Abstract][Full Text] [Related]
25. 'Premium' plasma: isn't 'regular' blood safe enough?
Consum Rep; 1999 Sep; 64(9):61-3. PubMed ID: 10848094
[No Abstract] [Full Text] [Related]
26. Safety of blood supply for infectious diseases in Latin American countries, 1994-1997.
Schmunis GA; Zicker F; Cruz JR; Cuchi P
Am J Trop Med Hyg; 2001 Dec; 65(6):924-30. PubMed ID: 11792000
[TBL] [Abstract][Full Text] [Related]
27. Reporting serious hazards of transfusion: the SHOT program.
Williamson LM; Love EM
Transfus Med Rev; 1998 Jan; 12(1):28-35. PubMed ID: 9460188
[No Abstract] [Full Text] [Related]
28. Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Zimbabwe.
Mapako T; Janssen MP; Mvere DA; Emmanuel JC; Rusakaniko S; Postma MJ; van Hulst M
Transfusion; 2016 Jun; 56(6 Pt 2):1520-8. PubMed ID: 26801952
[TBL] [Abstract][Full Text] [Related]
29. [A preliminary study of viral cross-transmission in dentistry].
Zhou D; Yang Z; Tong W
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 Jul; 35(4):283-5. PubMed ID: 11780511
[TBL] [Abstract][Full Text] [Related]
30. Process evaluation for biopharmaceuticals: what is appropriate in process evaluation?
Lubiniecki AS; McAllister PR; Smith TM; Shadle PJ
Dev Biol Stand; 1996; 88():309-15. PubMed ID: 9119154
[No Abstract] [Full Text] [Related]
31. Why is it important to reduce the need for blood transfusion, and how can it be done?
Berger A
BMJ; 2002 Jun; 324(7349):1302. PubMed ID: 12039821
[No Abstract] [Full Text] [Related]
32. [Application of leukocyte-poor blood products. Work Group Blood Group Serology from the Medical Advisory Commission of the College for Blood Transfusion].
van Rhenen DJ; Brand A
Ned Tijdschr Geneeskd; 1995 Jun; 139(22):1124-6. PubMed ID: 7791908
[No Abstract] [Full Text] [Related]
33. Reply. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica 2007;92:846-9.
Gröner A
Haematologica; 2008 Feb; 93(2):e24-6; author reply e27. PubMed ID: 18245642
[No Abstract] [Full Text] [Related]
34. Risk of virus transmission by tissue, blood, and plasma products.
Lelie PN; Zaaijer HL; Cuypers HT
Transplant Proc; 1996 Oct; 28(5):2939. PubMed ID: 8908132
[No Abstract] [Full Text] [Related]
35. Blood donations: justifying blood donor restrictions.
Spence JN; Iqbal FM
Br J Haematol; 2016 Sep; 174(5):822-3. PubMed ID: 26492347
[No Abstract] [Full Text] [Related]
36. [Trends in the evaluation of chemical disinfectants as virucides].
Weinhold E
Tierarztl Prax; 1973; 1(2):129-32. PubMed ID: 4807583
[No Abstract] [Full Text] [Related]
37. [Severe complications, adverse effects due to blood transfusion and its measures--transfusion transmitted viral infections].
Inaba S
Nihon Rinsho; 1997 Sep; 55(9):2320-6. PubMed ID: 9301297
[TBL] [Abstract][Full Text] [Related]
38. Safety of the blood supply in the United States: opportunities and controversies.
AuBuchon JP; Birkmeyer JD; Busch MP
Ann Intern Med; 1997 Nov; 127(10):904-9. PubMed ID: 9382369
[TBL] [Abstract][Full Text] [Related]
39. Disinfectant receptacle for applanation tonometers.
Van Buskirk EM
Am J Ophthalmol; 1987 Sep; 104(3):307-8. PubMed ID: 3631193
[No Abstract] [Full Text] [Related]
40. Transfusion-induced alloimmunization and immunosuppression and the effects of leukocyte depletion.
Meryman HT
Transfus Med Rev; 1989 Jul; 3(3):180-93. PubMed ID: 2520553
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
